» Articles » PMID: 34529827

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear Hormone Receptors

Abstract

The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point-in-time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15540. Nuclear hormone receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: G protein-coupled receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid-2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC-IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.

Citing Articles

Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2.

Lewandowski M, Busch R, Marschner J, Merk D ACS Pharmacol Transl Sci. 2025; .

PMID: 40046426 PMC: 7617459. DOI: 10.1021/acsptsci.4c00719.


Comparative effectiveness of sildenafil citrate and estradiol valerate as adjuvants during clomiphene citrate-assisted ovarian stimulation cycles in patients with unexplained infertility: a double-blind randomized controlled trial.

Bosenge-Nguma J, Oyandjo A, Djangeinga R, Skv J, Otuli N, Ntokamunda J Contracept Reprod Med. 2024; 9(1):48.

PMID: 39385289 PMC: 11462857. DOI: 10.1186/s40834-024-00307-6.


Safety Implications of Modulating Nuclear Receptors: A Comprehensive Analysis from Non-Clinical and Clinical Perspectives.

Rao M, McDuffie E, Srivastava S, Plaisted W, Sachs C Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065726 PMC: 11279859. DOI: 10.3390/ph17070875.


LowTempGAL: a highly responsive low temperature-inducible GAL system in Saccharomyces cerevisiae.

Lu Z, Shen Q, Bandari N, Evans S, McDonnell L, Liu L Nucleic Acids Res. 2024; 52(12):7367-7383.

PMID: 38808673 PMC: 11229376. DOI: 10.1093/nar/gkae460.


Quantitative analysis of the UDP-glucuronosyltransferase transcriptome in human tissues.

Zhou L, Montalvo A, Collins J, Wang D Pharmacol Res Perspect. 2023; 11(6):e01154.

PMID: 37983911 PMC: 10659769. DOI: 10.1002/prp2.1154.


References
1.
Stehlin-Gaon C, Willmann D, Zeyer D, Sanglier S, Van Dorsselaer A, Renaud J . All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol. 2003; 10(10):820-5. DOI: 10.1038/nsb979. View

2.
Millan D . What is the potential for inhaled p38 inhibitors in the treatment of chronic obstructive pulmonary disease?. Future Med Chem. 2011; 3(13):1635-45. DOI: 10.4155/fmc.11.96. View